Sagaliam Acquisition Corp Launches Improved IPF Formula With Vitamin C in Pill and Lozenge Form and Addition of New Slimming Neutraceutical
BAYTOWN, TX / ACCESSWIRE / May 1, 2024 / Sagaliam Acquisition Corp announced today that Virogentics, Inc., a wholly owned subsidiary of SAGA ,
Sagaliam Acquisition Corp. Announces Novation Agreement With Enzolytics, Inc.
NEW YORK, NY / ACCESSWIRE / April 26, 2024 / Sagaliam Acquisition Corp. ("SAGAU", "SAGA", SAGAR") (the "Company") announced that Sagaliam entered into a Novation Agreement with Enzolytics, Inc. (OTC P
Sagaliam Acquisition Corp.'s Nasdaq Delisting and OTC Transition
Sagaliam Acquisition To Delist From Nasdaq On March 6
Sagaliam Acquisition To Delist From Nasdaq On March 6
SAGALIAM ACQUISITION CORP. ANNOUNCES DELISTING OF COMMON SHARES FROM NASDAQ
New York, NY, March 07, 2024 (GLOBE NEWSWIRE) -- Sagaliam Acquisition Corp. (NASDAQ: "SAGAU", "SAGA", SAGAR") (the "Company") received a Nasdaq Hearing Withdrawal letter ("Notice") from the Listing Qualifications staff
With 45% Ownership, Saga Plc (LON:SAGA) Has Piqued the Interest of Institutional Investors
Sagaliam Acquisition to Appeal Potential Nasdaq Delisting
Sagaliam Acquisition Corp. (SAGA) said late on Monday it received a delisting notification letter from the Nasdaq Stock Market on Dec. 5. The company said it intends to file an appeal and take "all po
Sagaliam Acquisition: Received a Delisting Notification Letter From Nasdaq Stk Market LLC >SAGA
Sagaliam Acquisition: Received a Delisting Notification Letter From Nasdaq Stk Market LLC >SAGA
Sagaliam Acquisition: Intends to File an Appeal, and Take All Possible Steps to Maintain Its Nasdaq Listing >SAGA
Sagaliam Acquisition: Intends to File an Appeal, and Take All Possible Steps to Maintain Its Nasdaq Listing >SAGA
Enzolytics Announces the Signing of the Business Combination Agreement With Sagaliam Acquisition Corp (SAGA)
COLLEGE STATION, TX / ACCESSWIRE / September 18, 2023 / Enzolytics, Inc. (OTC PINK:ENZC) (Enzolytics, Inc. announces today that it has executed the binding business combination agreement for the sale
Sagaliam Acquisition Receives Non-Compliance Notice From Nasdaq, Agrees to Acquire Enzolytics Subsidiaries
Sagalian Acquisition Corp. (SAGA) said Friday it has been notified that it is not in compliance with the Nasdaq Stock Market's listing rules due to its failure to timely file its quarterly report on F
Sagaliam Acquisition Corp Faces Nasdaq Delisting Over Non-compliance
Sagaliam Acquisition: Agreed to Purchase Biogenysis and Virogentics From Enzolytics >SAGA
Sagaliam Acquisition: Agreed to Purchase Biogenysis and Virogentics From Enzolytics >SAGA
Sagaliam Acquisition: Received a Delinquency Notification Letter From the Listing Qualifications Staff of the Nasdaq >SAGA
Sagaliam Acquisition: Received a Delinquency Notification Letter From the Listing Qualifications Staff of the Nasdaq >SAGA
SAGALIAM ACQUISITION CORP. ANNOUNCES EXECUTION OF DEFINITIVE BUSINESS COMBINATION AGREEMENT AND RECEIPT OF NASDAQ LISTING DELINQUENCY LETTER
Virogentics, Inc. Receives Permit for Export to Africa of the ITV-1 Immunotherapy Solidifying the Scheduled Administration of the Treatment
Sagaliam Acquisition Confirms Funding, Deadline Extension to Complete Business Combination >SAGA
Sagaliam Acquisition Confirms Funding, Deadline Extension to Complete Business Combination >SAGA
Sagaliam Acquisition Names Ronnie Richardson, Krystine Miller, Travis Richardson to Board
Sagaliam Acquisition Names Ronnie Richardson, Krystine Miller, Travis Richardson to Board
SAGALIAM ACQUISITION CORP. ANNOUNCES RECEIPT OF NASDAQ LISTING DELINQUENCY LETTER AND APPOINTMENT OF INDEPENDENT DIRECTORS
New York, NY, July 28, 2023 (GLOBE NEWSWIRE) -- Sagaliam Acquisition Corp. (NASDAQ: "SAGAU", "SAGA", "SAGAR") ("we", "us", "our", or the "Company") announced today that it received a delinquency not
Enzolytics Inc. Files Supplemental Information Report on the Sale of Biogenysis, Inc. and Virogentics, Inc to Sagaliam Acquisition Corp.
COLLEGE STATION, TX / ACCESSWIRE / July 11, 2023 / Enzolytics, Inc. (OTC PINK:ENZC) (Enzolytics, Inc. ("ENZC" or the "Company") filed a Supplemental Information report today to provide additional deta
No Data